TLR7 and HIV infectious disease: In contrast, Buitendijk et al., showed that in addition to HIV inhibition in activated PBMC, gardiquimod, another TLR7 agonist, could inhibit the HIV infection of macrophages when the cells were treated prior to or shortly after infection [12].